Analyze Diet
The Veterinary clinics of North America. Equine practice1999; 14(3); 607-vii; doi: 10.1016/s0749-0739(17)30189-x

Equine sarcoids.

Abstract: Sarcoids, the most common tumor of the horse, are fibroblastic, wart-like skin lesions that show variable manifestations. They are often invasive and recurrent, although they do not fulfill all criteria of malignancy. Due to their anatomic location, these tumors can sometimes cause loss of use of the horse. There is very strong evidence that sarcoids are caused by viruses closely related or identical to bovine papilloma viruses, and genetic studies have shown associations between genes in or near the equine major histocompatibility complex (MHC) and susceptibility to sarcoid. Several types of treatments have been successful in treating sarcoids, although the response to therapy is not consistent. Current treatment of sarcoids primarily involves antitumor therapy, but the development of preventative measures in the future may be directed against the causative papilloma virus. Sarcoid continues to be an important clinical entity for the equine practitioner.
Publication Date: 1999-01-19 PubMed ID: 9891727DOI: 10.1016/s0749-0739(17)30189-xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article is about sarcoids, the most common tumors in horses, discussing their characteristics, causes, links to certain genes, and current treatment and prevention methods.

Understanding Equine Sarcoids

  • Sarcoids, described as fibroblastic, wart-like skin lesions, are the most common type of tumor found in horses. They have different manifestations and typically invade and recur multiple times. Although they have some characteristics of malignancy, they don’t fulfill all the criteria.
  • The tumors’ position in the horse body can sometimes lead to loss of use of certain parts of the horse body.

Cause of Sarcoids and Genetic Associations

  • Research has provided strong evidence that sarcoids are caused by viruses related or identical to bovine papilloma viruses. In essence, these are viruses common in cattle that might also affect horses, leading to the development of sarcoids.
  • Genetic studies have discovered links between genes in or near the equine major histocompatibility complex (MHC) and the susceptibility of horses to sarcoids.

Treatment of Sarcoids

  • Various treatment methods have been successful in addressing sarcoids. However, the response to therapy varies and is not consistent for all horses.
  • Presently, sarcoid treatment primarily involves antitumor therapy. This usually means medical procedures or medications administered to kill tumor cells or slow their growth.
  • There is a potential for the development of preventative measures in the future targeted against the causative papilloma virus. This would involve treatments designed to boost the horse’s immune system to fight off the virus, thus preventing the development of sarcoids.

Significance of the Study

  • The study highlights the clinical importance of understanding and treating sarcoids in horses. It provides insights into the current understanding of the cause and potential treatments for the condition, and provides a direction for future studies towards developing preventative measures.

Cite This Article

APA
Goodrich L, Gerber H, Marti E, Antczak DF. (1999). Equine sarcoids. Vet Clin North Am Equine Pract, 14(3), 607-vii. https://doi.org/10.1016/s0749-0739(17)30189-x

Publication

ISSN: 0749-0739
NlmUniqueID: 8511904
Country: United States
Language: English
Volume: 14
Issue: 3
Pages: 607-vii

Researcher Affiliations

Goodrich, L
  • College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
Gerber, H
    Marti, E
      Antczak, D F

        MeSH Terms

        • Animals
        • Horse Diseases / etiology
        • Horse Diseases / therapy
        • Horses
        • Leiomyoma / etiology
        • Leiomyoma / therapy
        • Leiomyoma / veterinary
        • Papillomaviridae / isolation & purification
        • Papillomavirus Infections / veterinary
        • Skin Neoplasms / etiology
        • Skin Neoplasms / therapy
        • Skin Neoplasms / veterinary
        • Tumor Virus Infections / veterinary

        Citations

        This article has been cited 10 times.
        1. Maggi R, De Paolis L, De Santis D, Vellone VG, De Ciucis CG, Fruscione F, Mazzocco K, Ghelardi A, Marruchella G, Razzuoli E. Bovine Papillomavirus Type 1 Infection in an Equine Congenital Papilloma.. Pathogens 2023 Aug 18;12(8).
          doi: 10.3390/pathogens12081059pubmed: 37624019google scholar: lookup
        2. Hainisch EK, Jindra C, Reicher P, Miglinci L, Brodesser DM, Brandt S. Bovine Papillomavirus Type 1 or 2 Virion-Infected Primary Fibroblasts Constitute a Near-Natural Equine Sarcoid Model.. Viruses 2022 Nov 28;14(12).
          doi: 10.3390/v14122658pubmed: 36560661google scholar: lookup
        3. Saba C, Eggleston R, Parks A, Peroni J, Sjoberg E, Rice S, Tyma J, Williams J, Grosenbaugh D, Leard AT. ALVAC-fIL2, a feline interleukin-2 immunomodulator, as a treatment for sarcoids in horses: A pilot study.. J Vet Intern Med 2022 May;36(3):1179-1184.
          doi: 10.1111/jvim.16425pubmed: 35416353google scholar: lookup
        4. Munday JS, Orbell G, Fairley RA, Hardcastle M, Vaatstra B. Evidence from a Series of 104 Equine Sarcoids Suggests That Most Sarcoids in New Zealand Are Caused by Bovine Papillomavirus Type 2, although Both BPV1 and BPV2 DNA Are Detectable in around 10% of Sarcoids.. Animals (Basel) 2021 Oct 29;11(11).
          doi: 10.3390/ani11113093pubmed: 34827825google scholar: lookup
        5. Palozzo A, Celani G, Guerri G, Straticò P, Varasano V, Petrizzi L. Segmental Posthetomy in a Four Stallions Case Series.. Animals (Basel) 2021 Apr 16;11(4).
          doi: 10.3390/ani11041145pubmed: 33923837google scholar: lookup
        6. Weber LA, Funtan A, Paschke R, Delarocque J, Kalbitz J, Meißner J, Feige K, Kietzmann M, Cavalleri JV. In vitro assessment of triterpenoids NVX-207 and betulinyl-bis-sulfamate as a topical treatment for equine skin cancer.. PLoS One 2020;15(11):e0241448.
          doi: 10.1371/journal.pone.0241448pubmed: 33151949google scholar: lookup
        7. Araldi RP, Assaf SMR, Carvalho RF, Carvalho MACR, Souza JM, Magnelli RF, Módolo DG, Roperto FP, Stocco RC, Beçak W. Papillomaviruses: a systematic review.. Genet Mol Biol 2017 Jan-Mar;40(1):1-21.
        8. Finlay M, Yuan Z, Morgan IM, Campo MS, Nasir L. Equine sarcoids: Bovine Papillomavirus type 1 transformed fibroblasts are sensitive to cisplatin and UVB induced apoptosis and show aberrant expression of p53.. Vet Res 2012 Dec 4;43(1):81.
          doi: 10.1186/1297-9716-43-81pubmed: 23210796google scholar: lookup
        9. Yuan ZQ, Nicolson L, Marchetti B, Gault EA, Campo MS, Nasir L. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.. J Virol 2008 Jul;82(13):6481-91.
          doi: 10.1128/JVI.00429-08pubmed: 18434409google scholar: lookup
        10. Postey RC, Appleyard GD, Kidney BA. Evaluation of equine papillomas, aural plaques, and sarcoids for the presence of Equine papillomavirus DNA and Papillomavirus antigen.. Can J Vet Res 2007 Jan;71(1):28-33.
          pubmed: 17193879